Pharmacare is a system of health insurance that provides people with access to necessary prescription drugs. National pharmacare could be structured to cover the drug costs of all Canadians, regardless of their ability to pay (like Canada’s insurance coverage for doctor and hospital care). Alternatively, it could be ‘means-tested’ and provide coverage for individuals only when their drug costs exceed a certain percentage of their income.
Which approach do you think is preferable and why? Share your thoughts below:
Thank you for your interest in this consultation with the Advisory Council on the Implementation of National Pharmacare.
The online consultation is now closed, and written submissions are no longer being accepted.
In March 2019, the Council provided an interim report to the Minister of Health and the Minister of Finance on the progress of their work.
The Council released its final report in June 2019.
For more information on the Council, please visit the following link: www.canada.ca/pharmacare.
Keep in touch with us via email at firstname.lastname@example.org.
Advisory Council on the Implementation of National Pharmacare